DÄ internationalArchive25/2020The treatment of mild and moderate asthma in adults


The treatment of mild and moderate asthma in adults

Dtsch Arztebl Int 2020; 117: 434-43. DOI: 10.3238/arztebl.2020.0434

Lommatzsch, M; Buhl, R; Korn, S

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Abteilung für Pneumologie, Zentrum für Innere Medizin, Universitätsmedizin Rostock: Prof. Dr. med. Marek Lommatzsch
Schwerpunkt Pneumologie, III. Medizinische Klinik, Universitätsmedizin Mainz: PD Dr. med. Stephanie Korn, Prof. Dr. med. Roland Buhl
1.To T, Stanojevic S, Moores G, et al.: Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC public health 2012; 12: 204 CrossRef MEDLINE PubMed Central
2.Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017; 5: 691–706 CrossRef
3.Sears MR: Trends in the prevalence of asthma. Chest 2014; 145: 219–25 CrossRef MEDLINE
4.Langen U, Schmitz R, Steppuhn H: Häufigkeit allergischer Erkrankungen in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 698–706 CrossRef MEDLINE
5.Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention. www.ginasthma.org, Update 2019, (last accessed on 14 April 2020).
6.Buhl R, Bals R, Baur X, et al.: Guideline for the diagnosis and treatment of asthma – guideline of the German Respiratory Society and the German Atemwegsliga in cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology. Pneumologie 2017; 71: 849–919.
7.Nationale Versorgungsleitlinie (NVL) Asthma. www.leitlinien.de/nvl/asthma 2020; 4. Auflage, AWMF-Register-Nr.: nvl-002. (last accessed on 14 April 2020).
8.Pavord ID, Beasley R, Agusti A, et al.: After asthma: redefining airways diseases. Lancet 2018; 391: 350–400 CrossRef
9.Lommatzsch M: Immune-modulation in asthma: current concepts and future strategies. Respiration 2020; In press CrossRef MEDLINE
10.Lambrecht BN, Hammad H, Fahy JV: The cytokines of asthma. Immunity 2019; 50: 975–91 CrossRef MEDLINE
11.Lommatzsch M, Klein M, Stoll P, Virchow JC: Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma. Thorax 2019; 74: 417–8 CrossRef MEDLINE
12.Dweik RA, Boggs PB, Erzurum SC, et al.: An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602–15 CrossRef MEDLINE PubMed Central
13.O‘Byrne PM, Reddel HK, Eriksson G, et al.: Measuring asthma control: a comparison of three classification systems. Eur Respir J 2010; 36: 269–76 CrossRef MEDLINE
14.Lommatzsch M, Virchow JC: Severe asthma: definition, diagnosis and treatment. Dtsch Arztebl Int 2014; 111: 847–55 VOLLTEXT
15.Bateman ED, Esser D, Chirila C, et al.: Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis. J Allergy Clin Immunol 2015; 136: 914–22 CrossRef MEDLINE
16.Shah L, Wilson AJ, Gibson PG, Coughlan J: Long acting beta-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2003: Cd001281 CrossRef
17.Nwaru BI, Ekstrom M, Hasvold P, Wiklund F, Telg G, Janson C: Overuse of short-acting beta2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme. Eur Respir J 2020 CrossRef MEDLINE PubMed Central
18.Reddel HK, FitzGerald JM, Bateman ED, et al.: GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J 2019; 53 CrossRef MEDLINE
19.Sobieraj DM, Weeda ER, Nguyen E, et al.: Association of inhaled corticosteroids and long-acting beta-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. Jama 2018; 319: 1485–96 CrossRef CrossRef MEDLINE PubMed Central
20.O‘Byrne PM, FitzGerald JM, Bateman ED, et al.: Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med 2018; 378: 1865–76 CrossRef CrossRef MEDLINE
21.Beasley R, Holliday M, Reddel HK, et al.: Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med 2019; 380: 2020–30 CrossRef MEDLINE
22.Hardy J, Baggott C, Fingleton J, et al.: Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet 2019; 394: 919–28 CrossRef
23.Henneberger PK, Patel JR, de Groene GJ, et al.: Workplace interventions for treatment of occupational asthma. Cochrane Database Syst Rev 2019; 10: Cd006308 CrossRef MEDLINE
24.Pfaar O, Agache I, de Blay F, et al.: Perspectives in allergen immunotherapy: 2019 and beyond. Allergy 2019; 74: 3–25 CrossRef MEDLINE
25.Liste der AIT-Präparate mit Wirksamkeitsnachweis, Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI): www.dgaki.de/leitlinien/s2k-leitlinie-sit/sit-produkte-studien-zulassung/ (last accessed on 14 April 2020).
26.Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID: Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology. Am J Respir Crit Care Med 2019; 199: 1471–7 CrossRef MEDLINE
27.Chauhan BF, Ducharme FM: Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database Syst Rev 2014: Cd003137 CrossRef
28.Weiler JM, Brannan JD, Randolph CC, et al.: Exercise-induced bronchoconstriction update-2016. J Allergy Clin Immunol 2016; 138: 1292–5.e36 CrossRef MEDLINE
29.Carson KV, Chandratilleke MG, Picot J, Brinn MP, Esterman AJ, Smith BJ: Physical training for asthma. Cochrane Database Syst Rev 2013: Cd001116 CrossRef MEDLINE
30.Robijn AL, Jensen ME, McLaughlin K, Gibson PG, Murphy VE: Inhaled corticosteroid use during pregnancy among women with asthma: A systematic review and meta-analysis. Clin Exp Allergy 2019; 49: 1403–17 CrossRef MEDLINE
31.Buhl R, FitzGerald JM, Busse WW: Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta2-agonists for adults with asthma. Respir Med 2018; 143: 82–90 CrossRef MEDLINE
32.Wang L, Zhou R, Xie X: Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis. J Asthma 2019; 56: 69–78 CrossRef MEDLINE
33.Maijers I, Kearns N, Harper J, Weatherall M, Beasley R: Oral steroid sparing effect of high dose inhaled corticosteroids in asthma. Eur Respir J 2020; 2: 55 CrossRef MEDLINE
34.Virchow JC, Kuna P, Paggiaro P, et al.: Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials. Lancet 2019; 394: 1737–49 CrossRef
35.Usmani OS, Lavorini F, Marshall J, et al.: Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res 2018; 19: 10 CrossRef MEDLINE PubMed Central
36.Usmani OS: Choosing the right inhaler for your asthma or COPD patient. Ther Clin Risk Manag 2019; 15: 461–72 CrossRef MEDLINE PubMed Central
37.Global Initiative for Asthma (GINA): Difficult-to-treat and severe asthma in adolescents and adult patients: diagnosis and management. www.ginasthma.org April 2019; Version 2.0 (last accessed on 14 April 2020).
38.Busse WW, Bateman ED, Caplan AL, et al.: Combined analysis of asthma safety trials of long-acting beta2-agonists. N Engl J Med 2018; 378: 2497–505 CrossRef MEDLINE
39.Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ: Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010: Cd005535 CrossRef PubMed Central
40.Sin DD, Man SF: Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Eur J Pharmacol 2006; 533: 28–35 CrossRef MEDLINE